FDA Drug Application (021641) for AZILECT by TEVA

Back to FDA Applications sponsored by TEVA

Application Number021641
Product Number001
FormTABLET;ORAL
DosageEQ 0.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameAZILECT
Active IngredientRASAGILINE MESYLATE

Active IngredientCount
List of drugs with Active Ingredient RASAGILINE MESYLATE2


Back to FDA Applications sponsored by TEVA